Soleno Therapeutics ( (SLNO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Soleno Therapeutics’ stock has been buoyed by positive sentiment in the healthcare sector, with analysts maintaining a strong buy consensus. This optimism is driven by strategic company developments and favorable market conditions. Despite the stock closing at $60.12, analysts have set an average price target of $119.60, suggesting a significant potential upside.
More about Soleno Therapeutics
YTD Price Performance: 31.52%
Average Trading Volume: 1,845,086
Technical Sentiment Signal: Buy
Current Market Cap: $3.2B
For further insights into SLNO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.